Mammoth Biosciences is harnessing the diversity of nature to power the next-generation of CRISPR products. Through the discovery and development of novel CRISPR systems, the company is enabling the full potential of its platform to improve lives by reading and writing the code of life. Mammoth aims to democratize disease detection with an easy and affordable point-of-care test that allows real-time and simultaneous detection of multiple conditions. By leveraging its internal research and development and exclusive licensing to Cas12, Cas13, Cas14, and CasΦ, Mammoth can provide enhanced diagnostics and genome editing for life science research, healthcare, agriculture, biodefense and more. Based in San Francisco, Mammoth Biosciences is co-founded by CRISPR pioneer Jennifer Doudna and principal founders Trevor Martin, Janice Chen, and Lucas Harrington. The firm is backed by top institutional investors including Mayfield, NFX, and 8VC, Decheng and leading individual investors including Brook Byers, Tim Cook, and Jeff Huber.

Biotechnology

Mammoth Biosciences

Mammoth Biosciences' headquarters in Brisbane, CA, United States

Trevor Martin

Jeanne G.

January Chi

Laura Smith

Gabor Veres

Siang Chin

Phil Tinmouth

Janice Chen

Lucas Harrington

Elaine Sun

Jeff Huber

Maneesh Jain

Jennifer Doudna

Kathie Bishop

Dinah Sah

Brigit Riley

Charles Albright

Amrit Nagpal

Description

People (29)

Jeff Huber

Maneesh Jain

Brigit Riley

Mandy W.

Kathy Kolodziej

Sanjay Parate

Wesley Addison

Adam Garske

Matan Drory Retwitzer

Gabriella Alvarez

Jacopo Baglieri

Jacqueline Laurel

Jason Lin

Karina Kono

Peng Wang

Renan Sper Dvm

Sameera Qureshi

Aashish Lamichhane

Maria Hargreaves

Rachel Herder

Matthew Verosloff

Leann Teadt

Monisha Vatikuti

Ria Shah

January Chi

Xin Miao

Wei-Cheng Chang

Xinyi Sui

Byron Lam

Jobs